Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
00:00 Share

Guest: Vivek Subbiah, MD

This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling )for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.